Purpose

The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.

Category

IRB Number
20180851HU
NCT Number
-
Sponsor
University of Sydney -



Study Contact

Principal Investigator
Gail Tomlinson



Eligibility

Eligible Ages
Between 11 Years and 45 Years
Eligible Genders
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

    Exclusion Criteria


      Study Design

      Arm Groups